Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a post on X:
“This is a good piece…
“But whether detection of molecular recurrences helps patients live longer or live better is a question that has yet to be answered — and one that can be addressed only with an RCT.””
Ttile: Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?
Authors: H. Gilbert Welch and Lesly A. Dossett
You Can Read The Full Article in The New England Journal of Medicine.
More posts featuring Thor Halfdanarson at OncoDaily.com.